Delaware MPJE Practice Exam 2026 – Complete Study Resource

In Delaware, the limits on dispensing Schedule II substances are generally set at a 30-day supply, which is the standard practice across the state to ensure both patient safety and the appropriate management of controlled substances. This limit is designed to minimize the risk of abuse and ensure that patients are regularly monitored by their healthcare providers.

While there are specific exceptions that may allow for a longer supply to be dispensed—such as in the case of chronic pain management where a physician may justify a longer duration under certain circumstances—the general rule remains a 30-day supply. This framework supports the responsible use of these potent medications among patients who truly need them while curbing potential misuse.

Recognizing this framework is important for pharmacists, as it guides their dispensing practices and ensures compliance with both state and federal laws regarding controlled substances.